by Jordana Choucair | Sep 22, 2021 | Opioid/Substance Use Disorders
The AMA released a new report calling on lawmakers to “act now” on climbing rates of fatal and nonfatal drug overdoses. More than 93,000 people died of drug overdoses in 2020, representing a record high and an almost 30 percent increase in overall fatal overdoses from...
by Jordana Choucair | Sep 17, 2021 | Opioid/Substance Use Disorders
The Department of Justice (DOJ) filed a motion to block Purdue Pharma LP’s bankruptcy plan while the agency appeals a federal judge’s decision to approve the settlement. In the filing, William K. Harrington, the DOJ’s U.S. trustee, said the deal –...
by Jordana Choucair | Sep 15, 2021 | Opioid/Substance Use Disorders
A Modern Healthcare article highlights examples of how insurers are adding benefits around substance abuse treatment. A number of insurers – including Highmark Health, Anthem, UnitedHealth Group’s Optum, and Beacon Magellan – have partnered with Ria Health to...
by Jordana Choucair | Sep 2, 2021 | Opioid/Substance Use Disorders
A federal judge conditionally approved Purdue Pharma LP’s bankruptcy settlement, requiring the Sackler family to pay $4.5 billion over nine years to fund addiction treatment and prevention initiatives across the country. The settlement also requires that the...
by Jordana Choucair | Sep 1, 2021 | Opioid/Substance Use Disorders
A federal bankruptcy judge is expected to rule today on whether to accept a settlement between Purdue Pharma and the states and thousands of local governments over the opioid crisis. If the judge confirms the $10 billion plan, members of the Sackler family would give...
by webmaster | Aug 24, 2021 | Opioid/Substance Use Disorders
At least six states haven’t fully signed on to a proposed $5 billion settlement with Johnson & Johnson and a $21 billion settlement with major drug distributors McKesson Corp., AmerisourceBergen Corp., and Cardinal Health Inc. over their role in the opioid...
Recent Comments